Archer Investment Corp - QUALIGEN THERAPEUTICS INC ownership

QUALIGEN THERAPEUTICS INC's ticker is and the CUSIP is 74754R202. A total of 15 filers reported holding QUALIGEN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Archer Investment Corp ownership history of QUALIGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$16
+6.7%
160.0%0.00%
Q2 2023$150.0%160.0%0.00%
Q1 2023$15
-28.6%
160.0%0.00%
Q4 2022$21160.00%
Other shareholders
QUALIGEN THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
HighMark Wealth Management LLC 8,009$8,0890.01%
Tower Research Capital LLC (TRC) 4,955$5,0050.00%
JPMORGAN CHASE & CO 387$3910.00%
ROYAL BANK OF CANADA 4$00.00%
VANGUARD GROUP INC 22,827$23,0550.00%
FMR LLC 2$20.00%
US BANCORP \DE\ 824$8320.00%
WELLS FARGO & COMPANY/MN 37$370.00%
NORTHERN TRUST CORP 11,919$12,0380.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of QUALIGEN THERAPEUTICS INC shareholders